HCW Biologics Inc. (HCWB) financial statements (2022 and earlier)

Company profile

Business Address 2929 N COMMERCE PKWY
MIRAMAR, FL 33025
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments36,714
Cash and cash equivalents11,731
Short-term investments24,984
Receivables133
Prepaid expense2,197
Other current assets1,437
Total current assets:40,480
Noncurrent Assets
Property, plant and equipment1,119
Long-term investments and receivables11,522
Long-term investments11,522
Other noncurrent assets393
Total noncurrent assets:13,034
TOTAL ASSETS:53,515
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,100
Accounts payable224
Other undisclosed accounts payable and accrued liabilities1,876
Other undisclosed current liabilities222
Total current liabilities:2,322
Noncurrent Liabilities
Total liabilities:2,322
Stockholders' equity
Stockholders' equity attributable to parent, including:51,193
Additional paid in capital81,827
Accumulated deficit(30,637)
Other undisclosed stockholders' equity attributable to parent4
Total stockholders' equity:51,193
TOTAL LIABILITIES AND EQUITY:53,515

Income statement (P&L) ($ in thousands)

12/31/2021
Operating expenses(13,368)
Operating loss:(13,368)
Interest and debt expense567
Loss from continuing operations before equity method investments, income taxes:(12,801)
Other undisclosed loss from continuing operations before income taxes(62)
Net loss available to common stockholders, diluted:(12,862)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(12,862)
Comprehensive loss, net of tax, attributable to parent:(12,862)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: